Publications

Skip to content

Publications

Explore Flatiron-authored research

Analysis of real-world progression and insufficient response variables and related endpoints among patients with non-Hodgkin lymphoma

Advances in Therapy

Richey M, Fullerton C, Zhang Q, et al

March 2025

publication-summary-analysis-of-real-world-progression-with-insufficient-response-variables-and-related-endpoints-among-patients-with-non-hodgkin-lymphoma

1,800 publications—and counting

To date, over 1,800 publications—authored by either Flatiron or our partners—have used Flatiron’s real-world data

Explore a list of all publications

See the impact of our data

Database Characterization Guide

An overview of Flatiron Health EHR-derived US data for journal reviewers and readers to better understand the data used in publications

Review our guide

Explore our summaries of Flatiron-authored research

Disease area

Acute myeloid leukemia

Breast cancer

Chronic lymphocytic leukemia

Colorectal cancer

Diffuse large B-Cell lymphoma

Gastric/Esophageal cancer

Head and neck cancer

Hepatocellular carcinoma

Melanoma

Metastatic breast cancer

Multiple myeloma

Non-small cell lung cancer

Ovarian cancer

Pancreatic cancer

Prostate cancer

Renal cell carcinoma

Small cell lung cancer

Tumor agnostic

Urothelial cell carcinoma

Topics

Comparative effectiveness

Drug discovery

HTA and market access

Health equity

Label expansion

Machine learning

Methodology

Prospective study

Quality improvement

Quality reporting

Regulatory

Resistance ID

Treatment patterns

Unmet need

Showing 9 of 0 results

ESMO AI & Digital Oncology
November 2025
Privacy-preserving error analysis loop For ML-based extraction of oncology EHR data
Groizard L, Dolezalova N, Kushnir M, et al.
ESMO AI & Digital Oncology
November 2025
A framework for evaluating performance of LLM-based extraction from the electronic health record across different healthcare systems
Seidl-Rathkopf K, Schwarz A, Viani N, et al.
ESMO AI & Digital Oncology
November 2025
Structuring GDPR-compliant private networks to enable LLM-Extracted oncology data on pseudonymized patient EHR data in Europe
Ellsworth L, Groizard L, Stefan F, et al.
ESMO AI & Digital Oncology
November 2025
A pan-tumor and pan-country approach to LLM-based extraction of systemic therapies from the electronic health record
Viani N, Groizard L, Harrison K, et al.
ESMO AI & Digital Oncology
November 2025
Survival prediction in advanced NSCLC (aNSCLC) amid evolving standards of care (SOC): Digital twin modeling incorporating LLM-extracted clinical context
Estevez M, Griffith S, Williams T, et al.
ASH Annual Meeting
November 2025
Real-world treatment patterns and survival outcomes in second and third line settings in large B-cell lymphoma
McGuirk J, Perales M, Fesen M, et al.
ASH Annual Meeting
November 2025
Real-world measurable residual disease (MRD) testing patterns and associated outcomes in patients with Philadelphia-negative B-cell acute lymphoblastic leukemia
Proli A, Sharpe J, Wang J, Collins J, Sawas A.
- Publication summary
- Publications
ASH Annual Meeting
November 2025
Use and outcomes following blinatumomab rechallenge in adolescents and young adults and adults with B-cell acute lymphoblastic leukemia
Use and outcomes following blinatumomab rechallenge in adolescents and young adults and adults with B-cell acute lymphoblastic leukemia (B-ALL)
ASH Annual Meeting
November 2025
Real-world insights into diffuse large B-cell lymphoma from EHR-derived data in Germany and the United Kingdom
Buhl C, Sawas A, Sujenthiran A, Ali M, Adamson B
- Publication summary
- Publications

Reimagining the infrastructure of cancer care

Resources
Publications
Company
Media
Careers
Contact Us

Clinical Research
Real-World Evidence
Point of Care

Legal, Privacy, and Compliance
Cookie Settings
© FLATIRON HEALTH® 2025